Dr. Veenoo Agarwal is the Head of the Medical Oncology Unit at Shalby International Hospitals, Gurugram. With extensive expertise in the management of solid organ cancers, he specializes in breast, neuroendocrine, colon, genitourinary, and other cancers. He is skilled in advanced treatments including immunotherapy, targeted immunotherapy, chemotherapy, and antibody-drug conjugate therapy. Dr. Agarwal completed his MBBS from Christian Medical College, Ludhiana, followed by FRACP from the Royal Australasian College of Physicians, and is pursuing a Master of Clinical Research from the University of Western Australia. He has served as a Medical Oncology Consultant in leading hospitals across India and Australia, and has been a Research Fellow focusing on neuroendocrine tumors and breast cancer. He has contributed to the scientific community with multiple publications in top oncology journals, including reviews on EMT in cancer, antibody-drug conjugates in breast cancer, and original research on mammographic breast density and chemotherapy outcomes.
Education
MBBS – Christian Medical College, Ludhiana (2001)
FRACP - Royal Australasian College of Physician (2019)
Master of Clinical Research - University of Western Australia (2025)
Experience
Medical Oncology Unit Head - Shalby International Hospitals, Gurugram
Medical Oncology Consultant -1. Narayana Multispeciality Hospital, Gurugram
Millennium Cancer Centre, Gurugram
Peter Copulos Cancer & Wellness Centre, Victoria, Australia
Whyalla General Hospital, South Australia
Research Fellow-
Medical Oncology Senior Registrar - Fiona Stanley Hospital /Sir Charles Gairdner Hospital, Western Australia
Expertise
Breast Cancer
Neuroendocrine Cancer
Colon Cancer
Genitourinary Cancer
All other Solid Organ Cancers
Immunotherapy
Targeted Immunotherapy
Chemotherapy
Antibody Drug Conjugate Therapy
Specialisation
Breast Cancer
Neuroendocrine Cancer
Colon Cancer
Genitourinary Cancer
All other Solid Organ Cancers
Treatment
Immunotherapy
Targeted Immunotherapy
Chemo Therapy
Antibody Drug Conjugate Therapy
Publications
Review Article –: “EMT and Cancer: What Clinicians should know”. Nature Review Clinical Oncology, 2025 Jul 22.
Review Article - Antibody-Drug Conjugate Review in Breast Cancer: A Targeted Approach. International Journal of Molecular and Immuno Oncology -2024
Review article - Anoxia as a signal for prison breakout in Cancer.
Original research - Correlations Between Mammographic Breast Density and Outcomes After Neoadjuvant
Chemotherapy in Patients with Locally Advanced Breast Cancer.